CRP and Heart Attack Risk: What Your Inflammation Number Predicts
Cholesterol tells only half the story of cardiovascular risk. The other half is inflammation, and high-sensitivity CRP is the number that captures it.
Written by Sydney Murphy, CMO & Digital Products Officer. Reviewed by the Sensa Wellness editorial team. Written to reflect current, publicly available inflammation research.
High-sensitivity CRP (hsCRP) is an independent predictor of heart attack and stroke, meaning it adds risk information beyond cholesterol and blood pressure. For cardiovascular risk, an hsCRP below 1 mg/L signals low risk, 1 to 3 mg/L is average risk, and above 3 mg/L indicates high risk. Because vascular inflammation drives the growth and rupture of arterial plaques, a persistently elevated hsCRP can flag danger even when your LDL cholesterol looks acceptable.
For decades, cardiovascular risk was framed almost entirely around cholesterol. If your LDL was high, you were at risk; if it was controlled, you were reassured. But cardiologists kept encountering a frustrating reality: roughly half of all heart attacks occur in people with normal or only modestly elevated cholesterol. Something else was contributing to the process, and that something turned out to be inflammation.
C-reactive protein, measured with the high-sensitivity assay, has emerged as one of the most useful blood markers for capturing that inflammatory component of cardiovascular risk. It does not measure cholesterol or plaque directly. Instead it reflects the low-grade inflammation smoldering in artery walls, and that inflammation is central to how heart attacks actually happen. Understanding what your CRP number predicts, and where it fits alongside the inflammatory biology of heart disease, can meaningfully change how you think about prevention.
Why Inflammation Drives Heart Attacks
Atherosclerosis is an inflammatory disease. The old picture of coronary disease was a plumbing problem: cholesterol slowly clogging a pipe until it closed. The modern understanding is very different. Atherosclerotic plaque forms when LDL particles penetrate the artery wall, become oxidized, and trigger an immune response. White blood cells migrate into the wall, engulf the cholesterol, and become foam cells, releasing inflammatory signals that recruit still more immune cells. The plaque that results is not an inert clog but an actively inflamed lesion.
As Paul Ridker, MD, Harvard Medical School professor and director of the Center for Cardiovascular Disease Prevention at Brigham and Women's Hospital, put it in Harvard Health Publishing: "Over the past 30 years, research has shown that inflammation is as important as cholesterol in the development of atherosclerosis."
Rupture, not gradual blockage, causes most heart attacks. The plaques most likely to trigger a heart attack are often not the largest ones. They are the inflamed, unstable ones with thin fibrous caps. When the inflammation within a plaque weakens its cap, the plaque can rupture, exposing its contents to the bloodstream and triggering a clot that abruptly blocks the artery. This is why inflammation matters so much: it governs whether a plaque stays stable or becomes the trigger for a sudden cardiac event.
CRP reflects that vascular inflammation. C-reactive protein is produced by the liver in response to inflammatory cytokines, particularly interleukin-6, that are elevated when arterial inflammation is active. It is not thought to be a bystander only; some evidence suggests CRP may participate in the inflammatory process itself. Either way, a higher hsCRP indicates a more inflamed internal environment, which is precisely the environment in which plaques grow and destabilize. This connects CRP to the broader picture of silent, low-grade inflammation that can persist for years without symptoms.
Reading the Cardiovascular Risk Cutoffs
The three-tier framework. For cardiovascular risk assessment, hsCRP results are grouped into three bands. Below 1 mg/L corresponds to low relative risk. Between 1 and 3 mg/L corresponds to average risk. Above 3 mg/L corresponds to high relative risk. These cutoffs were established through large population studies and are widely used to add nuance to conventional risk calculators that rely on cholesterol, blood pressure, age, and smoking status.
Independent and additive. The important word is independent. hsCRP predicts cardiovascular events even after accounting for the traditional risk factors, and it is often most valuable in people whose cholesterol-based risk is intermediate. A meta-analysis that pooled individual records from 160,309 people without prior vascular disease across 54 prospective studies found that each threefold higher CRP concentration was associated with roughly a 37 percent higher risk of coronary heart disease even after adjusting for conventional risk factors, with a similar relationship for ischemic stroke (Emerging Risk Factors Collaboration, Lancet, 2010). A person with borderline LDL and an hsCRP above 3 mg/L may carry meaningfully higher risk than their cholesterol alone would suggest, which can tip the balance toward more aggressive prevention. For a fuller explanation of the number itself, our guide to understanding your CRP results walks through interpretation in detail.
Interpreting a single very high value. A one-time hsCRP above 10 mg/L usually reflects an acute event such as an infection, injury, or flare of another condition rather than chronic cardiovascular inflammation. For cardiovascular risk assessment, the measurement should be taken when you are well, and ideally confirmed with a repeat test a couple of weeks apart, because CRP naturally fluctuates. A stable, persistently elevated value in the absence of acute illness is what carries the cardiovascular meaning.
What the JUPITER Trial Showed
Testing CRP-guided treatment. The single most influential study connecting CRP to heart attack prevention was the JUPITER trial. It enrolled people who did not have high LDL cholesterol by conventional standards but who did have an elevated hsCRP, essentially a group defined by inflammation rather than by cholesterol. These participants would not have qualified for statin therapy under cholesterol-based guidelines of the time.
A meaningful reduction in events. Participants were randomly assigned to a statin or a placebo. Among the 17,802 people enrolled, the statin cut the risk of the primary cardiovascular endpoint by 44 percent (hazard ratio 0.56) over a median follow-up of under two years, and roughly halved the rate of heart attack, compared with placebo (JUPITER trial, New England Journal of Medicine, 2008). The result was striking because it suggested that people with normal cholesterol but elevated inflammation could still benefit from therapy, extending prevention to a population that cholesterol screening alone would have missed.
Statins lower both cholesterol and inflammation. One reason the findings generated so much discussion is that statins reduce LDL and hsCRP at the same time, so the trial could not fully separate how much of the benefit came from each. What is clear is that hsCRP helped identify people who benefited, cementing its role as a tool for refining who might gain from earlier intervention. JUPITER did not make CRP a treatment target on its own, but it firmly established inflammation as a legitimate axis of cardiovascular risk alongside cholesterol.
Does Lowering Inflammation Itself Prevent Heart Attacks?
The question JUPITER left open. Because statins lower cholesterol and inflammation together, JUPITER could not answer whether reducing inflammation on its own, with lipids left untouched, would prevent cardiovascular events. That question was the whole point of the CANTOS trial, which tested canakinumab, an anti-inflammatory antibody that targets interleukin-1 beta, one of the upstream signals that drives CRP production.
Inflammation reduction alone reduced events. CANTOS enrolled 10,061 people who had already had a heart attack and still had an hsCRP of 2 mg/L or higher, a group with persistent residual inflammation despite standard care. The antibody lowered CRP without changing LDL cholesterol at all, and the most effective dose cut the risk of a repeat heart attack, stroke, or cardiovascular death by about 15 percent (hazard ratio 0.85) compared with placebo (CANTOS trial, New England Journal of Medicine, 2017). It was the first proof that targeting inflammation by itself, with no effect on lipids, could reduce cardiovascular risk.
What this means for a CRP number. CANTOS used an expensive injectable drug that is not a general prevention tool, and it does not change how an individual should act on a single result. But it validated the core idea behind tracking CRP for heart health: the inflammation that hsCRP reflects is not merely a passive marker riding alongside cholesterol, it is part of the causal machinery of heart attacks. That is why a persistently elevated hsCRP is worth understanding and, where possible, lowering through the everyday habits covered below.
Using Your CRP Number for Prevention
Context is everything. An hsCRP result is most useful as one input among several, interpreted alongside cholesterol, blood pressure, family history, and lifestyle, and discussed with a healthcare provider. On its own it does not diagnose heart disease, and an elevated value has many possible causes, including obesity, smoking, and other inflammatory conditions. Its power lies in adding an inflammatory dimension that traditional risk factors miss.
Inflammation responds to lifestyle. Unlike some risk markers, hsCRP is modifiable. Regular physical activity, weight loss, smoking cessation, and an anti-inflammatory dietary pattern rich in fiber, omega-3 fats, and plant foods have all been associated with lower CRP. This means the number is not just a warning light but a target you can influence, and tracking it over time can show whether your changes are working. Our guides to lowering CRP cover the evidence-based approaches in depth.
Where at-home testing fits. Because meaningful CRP change unfolds over weeks and months, a single lab draw offers only a snapshot. Sensa is a general wellness tool that tracks CRP at home, letting you establish a personal baseline and watch how it trends as you adjust exercise, diet, sleep, and other habits. Tracking that trend gives you and your provider a clearer, more continuous picture of your inflammatory status than an occasional office visit can provide.
Sources
- Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140. pubmed.ncbi.nlm.nih.gov/20031199
- Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). N Engl J Med. 2008;359(21):2195-2207. pubmed.ncbi.nlm.nih.gov/18997196
- Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS). N Engl J Med. 2017;377(12):1119-1131. pubmed.ncbi.nlm.nih.gov/28845751
- Inflammation and heart disease: A smoldering threat (Harvard Health Publishing): health.harvard.edu
Frequently Asked Questions
Does CRP predict heart attack risk?
Yes. High-sensitivity CRP is an independent predictor of heart attack and stroke, meaning it adds risk information beyond cholesterol and blood pressure. Because vascular inflammation drives the growth and rupture of arterial plaques, a persistently elevated hsCRP can flag danger even when LDL cholesterol looks acceptable. It is most useful as one input among several, interpreted alongside conventional risk factors.
What hsCRP level indicates high cardiovascular risk?
For cardiovascular risk assessment, an hsCRP below 1 mg/L signals low relative risk, 1 to 3 mg/L is average risk, and above 3 mg/L indicates high relative risk. A one-time value above 10 mg/L usually reflects an acute infection or injury rather than chronic cardiovascular inflammation, so the test should be taken when you are well and confirmed with a repeat measurement.
Why do heart attacks happen with normal cholesterol?
Roughly half of heart attacks occur in people with normal or only modestly elevated cholesterol because inflammation, not cholesterol alone, governs whether an arterial plaque stays stable or ruptures. Inflamed plaques with thin caps can rupture and trigger a clot that abruptly blocks the artery. hsCRP captures this inflammatory component of risk that cholesterol screening alone would miss.
What did the JUPITER trial show about CRP?
The JUPITER trial enrolled people with normal LDL cholesterol but elevated hsCRP, a group defined by inflammation rather than cholesterol. Treating them with a statin substantially reduced heart attacks, strokes, and cardiovascular deaths compared with placebo. Because statins lower both LDL and hsCRP, the trial could not fully separate the two effects, but it established inflammation as a legitimate axis of cardiovascular risk.
Can you lower your CRP to reduce heart risk?
hsCRP is modifiable. Regular physical activity, weight loss, smoking cessation, and an anti-inflammatory dietary pattern rich in fiber, omega-3 fats, and plant foods have all been associated with lower CRP. This makes the number a target you can influence rather than just a warning light, and tracking it over time can show whether your lifestyle changes are working.
Does reducing inflammation by itself prevent heart attacks?
Yes, there is direct trial evidence. The CANTOS trial tested an anti-inflammatory antibody in 10,061 people who had already had a heart attack and still had an hsCRP of 2 mg/L or higher. The drug lowered CRP without changing cholesterol and reduced the risk of a repeat cardiovascular event by about 15 percent, the first proof that targeting inflammation alone can lower heart risk. It used an injectable medication that is not a general prevention tool, but it confirmed that the inflammation hsCRP reflects is part of the causal process, not just a passive marker.
Track the inflammation behind your heart risk.
Sensa is a general wellness tool for measuring CRP levels at home. If you are working on heart-healthy habits, tracking your CRP trend can help you see how lifestyle changes are affecting your inflammatory baseline.
Buy Now